Literature DB >> 34717984

Epigenetic modifications from arsenic exposure: A comprehensive review.

Arijit Chakraborty1, Soma Ghosh1, Bratisha Biswas1, Sreemanta Pramanik1, Jerome Nriagu2, Subhamoy Bhowmick3.   

Abstract

Arsenic is a notorious element with the potential to harm exposed individuals in ways that include cancerous and non-cancerous health complications. Millions of people across the globe (especially in South and Southeast Asian countries including China, Vietnam, India and Bangladesh) are currently being unknowingly exposed to precarious levels of arsenic. Among the diverse effects associated with such arsenic levels of exposure is the propensity to alter the epigenome. Although a large volume of literature exists on arsenic-induced genotoxicity, cytotoxicity, and inter-individual susceptibility due to active research on these subject areas from the last millennial, it is only recently that attention has turned on the ramifications and mechanisms of arsenic-induced epigenetic changes. The present review summarizes the possible mechanisms involved in arsenic induced epigenetic alterations. It focuses on the mechanisms underlying epigenome reprogramming from arsenic exposure that result in improper cell signaling and dysfunction of various epigenetic components. The mechanistic information articulated from the review is used to propose a number of novel therapeutic strategies with a potential for ameliorating the burden of worldwide arsenic poisoning.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arsenic; DNA methylation; Histone PTM; Therapeutic interventions; microRNA

Mesh:

Substances:

Year:  2021        PMID: 34717984     DOI: 10.1016/j.scitotenv.2021.151218

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  1 in total

1.  Comprehensive Landscape of HOXA2, HOXA9, and HOXA10 as Potential Biomarkers for Predicting Progression and Prognosis in Prostate Cancer.

Authors:  Yan-Ping Song; Peng Xian; Hong Luo; Jun-Yong Dai; Yu Bai; Yuan Li; Xian-Li Tang
Journal:  J Immunol Res       Date:  2022-03-24       Impact factor: 4.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.